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Background
Tumor-infiltrating lymphocytes (TILs) is considered a
manifestation of the host immune response to tumor, but
the role of TILs on melanoma mortality is controversial.
Therefore, the aim of this study was to investigate the role
of TILs on melanoma mortality, controlling for all known
histological prognostic parameters.
Materials and methods
We conducted a 10-year cohort study among 4143
patients from the same geographic area (Lazio) with pri-
mary cutaneous melanoma diagnosed between January
1998 and December 2008. Survival probability was deter-
mined by Kaplan–Meier estimates, and prognostic factors
were evaluated by multivariate analysis (Cox proportional
hazards model).
Results
Survival decreased with increasing age (P for trend <
0.001) and Breslow thickness (P for trend < 0.001). In the
multivariate Cox model, the presence of high levels of
tumour infiltrating immune cells in primary invasive mela-
nomas was associated with lower risk of melanoma death
(RR: 0.32; 95%CI:0.13-0.82, P for trend <0.001), after con-
trolling for sex, age, breslow thickness, histological type,
mitotic rate and ulceration.
Conclusions
These results suggest that immune microenvironment
affects melanoma survival. Understanding differences in
survival across distinct subgroups of melanoma patients
may help choosing types of therapy.
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